Nanoformulated fingolimod attenuates NLRP3 inflammasome activation and promotes functional recovery in a rat model of spinal cord injury
Fields of Study & Subjects
Inflammasome and immune disorders
Spinal Cord Injury Research
Sphingolipid Metabolism and Signaling
Publication details
- Journal / source
- Spinal Cord
- Publisher
- Springer Science and Business Media LLC
- Volume
- 64
- Issue
- 8
- Pages
- 669–677
- Publication date
- 21 February 2026
- Language
- EN